Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options?

Published:2020-11-12 Issue:3 Volume:109 Page:591-604
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Knikman Jonathan E.¹,Gelderblom Hans²,Beijnen Jos H.¹³,Cats Annemieke⁴,Guchelaar Henk‐Jan⁵,Henricks Linda M.⁶

Affiliation:

1. Division of Pharmacology The Netherlands Cancer Institute Amsterdam The Netherlands

2. Department of Clinical Oncology Leiden University Medical Center Leiden The Netherlands

3. Department of Pharmaceutical Sciences Utrecht University Utrecht The Netherlands

4. Department of Gastroenterology and Hepatology Division of Medical Oncology The Netherlands Cancer Institute Amsterdam The Netherlands

5. Department of Clinical Pharmacy and Toxicology Leiden University Medical Center Leiden The Netherlands

6. Department of Clinical Chemistry and Laboratory Medicine Leiden University Medical Center Leiden The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2069

Reference98 articles.

1. 5-Fluorouracil: mechanisms of action and clinical strategies

2. Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis

3. Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

4. Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study

5. Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Partial protein binding of uracil and thymine affects accurate dihydropyrimidine dehydrogenase (DPD) phenotyping;Journal of Pharmaceutical and Biomedical Analysis;2024-10

2. Implementation of DPYD testing in Bulgarian patients with cancer;Biotechnology & Biotechnological Equipment;2024-08-07

3. Adverse drug events associated with fluorouracil use in patients with metastatic colorectal cancer: a real-world pharmacovigilance study based on the FDA adverse event reporting system;Expert Opinion on Drug Safety;2024-07-23

4. Artificial Intelligence-Driven Prediction Revealed CFTR Associated with Therapy Outcome of Breast Cancer: A Feasibility Study;Oncology;2024-07-18

5. Evaluation of early fluoropyrimidine toxicity in solid organ cancer patients: a retrospective observational study in Australia;Internal Medicine Journal;2024-07-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3